The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bagdasarova D.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Zikiryakhodzhaev A.D.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Russia;
Peoples’ Friendship University of Russia

Usov F.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Khmelevsky E.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Gerasimov A.N.

Central Research Institute for Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Duadze I.S.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Dzhabrailova D.Sh.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Laberko D.A.

People’s Friendship University of Russia

Batov M.A.

National Medical Research Radiological Centre

Prognostic factors in patients with primary operable breast cancer (cT1-2N0-1M0) after reconstructive plastic surgery with single-stage reconstruction using endoprosthesis

Authors:

Bagdasarova D.V., Zikiryakhodzhaev A.D., Usov F.N., Khmelevsky E.V., Gerasimov A.N., Duadze I.S., Dzhabrailova D.Sh., Laberko D.A., Batov M.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2022;11(4): 34‑38

DOI: 10.17116/onkolog20221104134

Read: 1616 times

Download PDF (RU)
Contact the author
Table of contents

PROGNOSTIC FACTORS IN PATIENTS WITH PRIMARY OPERABLE BREAST CANCER (CT1-2N0-1M0) AFTER RECONSTRUCTIVE PLASTIC SURGERY WITH SINGLE-STAGE RECONSTRUCTION USING ENDOPROSTHESIS
PROGNOSTIC FACTORS IN PATIENTS WITH PRIMARY OPERABLE BREAST CANCER (CT1-2N0-1M0) AFTER RECONSTRUCTIVE PLASTIC SURGERY WITH SINGLE-STAGE RECONSTRUCTION USING ENDOPROSTHESIS

To cite this article:

Bagdasarova DV, Zikiryakhodzhaev AD, Usov FN, et al. . Prognostic factors in patients with primary operable breast cancer (cT1-2N0-1M0) after reconstructive plastic surgery with single-stage reconstruction using endoprosthesis. P.A. Herzen Journal of Oncology. 2022;11(4):34‑38. (In Russ.)
https://doi.org/10.17116/onkolog20221104134

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83
Neoadjuvant drug therapy and onco­logical outcomes in patients with stage I–II breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(1):5-12
The choice of radiotherapy dose fractionation regi­men for grade 4 gliomas depe­nding on the status of MGMT. P.A. Herzen Journal of Onco­logy. 2025;(1):13-18
NDRG1 protein expression in breast cancer samples, rela­tionship with lymph nodes meta­stasis. Russian Journal of Archive of Pathology. 2024;(6):36-42
Impact of tumor size on actuarial survival of patients with primary breast sarcoma: a case-control study. Piro­gov Russian Journal of Surgery. 2024;(12):38-43
Asse­ssment of risk factors for breast cancer deve­lopment in women living in the Sara­tov region. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):100-106
Left ventricular myocardial performance index (Tei index) as an early marker of cardiotoxicity in anti­tumor therapy. Russian Cardiology Bulletin. 2024;(4-2):137-143
Nottingham Prognostic Index rela­tion to cyto­kine-producing tumor mole­cular subtypes in breast cancer. Russian Journal of Preventive Medi­cine. 2025;(1):63-68
The possibilities of predicting and redu­cing the risk of breast cancer in women against the background of the use of assi­sted reproductive technologies. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):59-64
Problems of pregnancy planning and gestation in patients with diffuse toxic goiter after radiotherapy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):82-87
Abstract:

OBJECTIVE

To identify poor prognostic factors and event-free survival rates in patients with primary operable breast cancer (BC) after single-stage reconstruction.

Subjects and methods. The investigation analyzed the data of 203 patients with BC who had undergone skin-sparing/subcutaneous mastectomy (SSME/SCME) with single-stage reconstruction using a silicone endoprosthesis within combined or combination treatment between 2008 to March 2018. The patients’ mean age at the time of surgery was 45.08±0.65 years (range 18—75 years). The median follow-up was 51 months (95% CI: 49 to 53 months); the mean follow-up was 60.3±1.9 months. SCME with single-stage reconstruction with a silicone endoprosthesis was performed in 71.4% of patients.

RESULTS

The cumulative relapse-free survival at 3 and 5 years was 100%; that at 10 years was 92.6% (95% CI: 81.9—100%). The mean time to progression was 30.9 months. The distant metastasis-free survival at 3 years was 97% (95% CI: 94.7—99.4%); and that at 10 years was 91.6% (95% CI: 86.7—96.6%). The 10-year tumor-specific survival in the entire patient group was 99.3%. The presence of lymphovascular invasion (p=0.048) and regional lymph node metastasis (p=0.008) was associated with worse event-free survival.

CONCLUSION

SSME/SCME with single-stage reconstruction using a silicone endoprosthesis is a safe surgical option for patients with BC. The risk of local recurrence and progression remains high within the next 5 years after the treatment and stable within the next 10 years.

Keywords:

breast cancer
mastectomy
single-stage breast reconstruction
radiotherapy
implant

Authors:

Bagdasarova D.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Zikiryakhodzhaev A.D.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Russia;
Peoples’ Friendship University of Russia

Usov F.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Khmelevsky E.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Gerasimov A.N.

Central Research Institute for Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Duadze I.S.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Dzhabrailova D.Sh.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Laberko D.A.

People’s Friendship University of Russia

Batov M.A.

National Medical Research Radiological Centre

Received:

22.04.2022

Accepted:

27.04.2022

Close metadata

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO. Zlokachestvennye novoobrazovaniya v Rossii v 2019 (zabolevaemost’ i smertnost’). M.: MNIOI imeni P.A. Gertsena — filial FGBU «NMITs radiologii» Ministerstva zdravookhraneniya Rossiiskoi Federatsii; 2020. (In Russ.).
  2. Galimberti V, Vicini E, Corso G, Morigi C, Fontana S, Sacchini V, Veronesi P. Nipple-sparing and skin-sparing mastectomy: review of aims, oncological safety and contraindications. Breast. 2017;34(suppl 1):82-84.  https://doi.org/10.1016/j.breast.2017.06.034
  3. Bernier J. Postoperative radiotherapy after nipple- or skin-sparing mastectomy: a review of recent institutional and pooled data. Ecancermedicalscience. 2018;12:834.  https://doi.org/10.3332/ecancer.2018.834
  4. Harcourt D, Rumsey N. Psychological aspects of breast reconstruction: a review of the literature. J Adv Nurs. 2001;35(4):477-487.  https://doi.org/10.1046/j.1365-2648.2001.01865.x
  5. Meretoja TJ, Rasia S, von Smitten KA, Asko-Seljavaara SL, Kuokkanen HO, Jahkola TA. Late results of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg. 2007;94(10):1220-1225. https://doi.org/10.1002/bjs.5815
  6. Zikiryakhodzhaev AD, Rasskazova EA. Retsidivy raka molochnoi zhelezy posle podkozhnykh radikal’nykh mastektomii s odnomomentnoi rekonstruktsiei. Issledovaniya i praktika v meditsine. 2014;1(1):24-28. (In Russ.). https://doi.org/10.17709/2409-2231-2014-1-1-24-28
  7. Zikiryakhodzhaev AD, Rasskazova EA, Khakimova ShG. Onkologicheskaya bezopasnost’ radikal’nykh podkozhnykh/kozhesokhrannykh mastektomii s odnomomentnoi rekonstruktsiei pri rake. Voprosy onkologii. 2019;65(6):832-837. (In Russ.). https://doi.org/10.37469/0507-3758-2019-65-6-832-837
  8. Lanitis S, Tekkis PP, Sgourakis G, Dimopoulos N, Al Mufti R, Hadjiminas DJ. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg. 2010;251(4):632-639.  https://doi.org/10.1097/SLA.0b013e3181d35bf8
  9. Santoro S, Loreti A, Cavaliere F, Costarelli L, La Pinta M, Manna E, Mauri M, Scavina P, Santini E, De Paula U, Toto V, Fortunato L. Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy. Breast. 2015;24(5):661-666.  https://doi.org/10.1016/j.breast.2015.08.001
  10. Galimberti V, Morigi C, Bagnardi V, Corso G, Vicini E, Fontana SKR, Naninato P, Ratini S, Magnoni F, Toesca A, et al. Oncological outcomes of nipple-sparing mastectomy: a single-center experience of 1989 patients. Ann Surg Oncol. 2018;25(13):3849-3857. https://doi.org/10.1245/s10434-018-6759-0
  11. NCCN clinical practice guidelines in oncology: breast cancer, version 2.2022. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.